Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial
Top Cited Papers
Open Access
- 3 November 2011
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 378 (9809) , 2104-2111
- https://doi.org/10.1016/s0140-6736(11)61095-7
Abstract
No abstract availableFunding Information
- US National Cancer Institute (grant CA077202)
- Canadian Cancer Society Research Institute (grant 14469)
- UK Medical Research Council (grant G9805643)
This publication has 30 references indexed in Scilit:
- External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised studyThe Lancet Oncology, 2010
- Cardiac and Cognitive Effects of Androgen Deprivation Therapy: Are They Real?Current Oncology, 2010
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008International Journal of Cancer, 2010
- Time Trends and Local Variation in Primary Treatment of Localized Prostate CancerJournal of Clinical Oncology, 2010
- Diabetes and Cardiovascular Disease During Androgen Deprivation Therapy for Prostate CancerJournal of Clinical Oncology, 2006
- Analysis and interpretation of health-related quality-of-life data from clinical trials: basic approach of The National Cancer Institute of Canada Clinical Trials GroupEuropean Journal Of Cancer, 2005
- An ICRU 50 radiotherapy treatment chartRadiotherapy and Oncology, 1995
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI Journal of the National Cancer Institute, 1993
- A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing RiskThe Annals of Statistics, 1988